Inpatient management of diabetes and hyperglycemia

Clinical Therapeutics

Volumn 35, Issue 5, 2013, Pages 724-733

  Bogun, Magdalena ^a   Inzucchi, Silvio E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical care; Diabetes; Hospital; Hyperglycemia; Inpatient; Insulin infusion

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN; PIG INSULIN; SULFONYLUREA DERIVATIVE;

ADVERSE OUTCOME; ARTICLE; DIABETES MELLITUS; DIETARY INTAKE; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE; META ANALYSIS (TOPIC); MORTALITY; OUTPATIENT CARE; PATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; UNITED STATES;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; INTENSIVE CARE;

EID: 84877896091     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.04.008     Document Type: Article

References (26)

1. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 782:1471-1478.
2. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008, 117:1018-1027.
3. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87:978-982.
4. Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diab Vasc Dis Res 2008, 5:269-275.
5. Furnary A.P., Wu Y., Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10 Suppl 2:21-33.
6. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997, 314:1512-1515. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.
7. Cheung N.W., Wong V.W., McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006, 29:765-770.
8. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005, 26:650-661.
9. Mehta S.R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005, 293:437-446.
10. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 3459:1359-1367.
11. van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461.
12. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 3603:1283-1297. NICE-SUGAR Study Investigators.
13. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180:821-827.
14. Kosiborod M., Inzucchi S.E., Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009, 3015:1556-1564.
15. Moghissi E.S., Korytkowski M.T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009, 32:1119-1131.
16. Wilson M., Weinreb J., Hoo G.W. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007, 30:1005-1011.
17. Shetty S., Inzucchi S.E., Goldberg P.A., et al. Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol. Endocr Pract 2012, 18:363-370.
18. Arabi Y.M., Dabbagh O.C., Tamim H.M., et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008, 362:3190-3197.
19. Preiser J.C., Devos P., Ruiz-Santana S., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol Study. Intensive Care Med 2009, 35:1738-1748.
20. De La Rosa Gdel C., Donado J.H., Restrepo A.H., et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008, 12:R120.
21. Baker E.H., Janaway C.H., Philips B.J., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006, 61:284-289.
22. Pomposelli J.J., Baxter J.K., Babineau T.J., et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998, 22:77-81.
23. Umpierrez G.E., Smiley D., Zisman A., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care 2007, 30:2181-2186.
24. Umpierrez G.E., Hor T., Smiley D., et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine Hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab 2009, 94:564-569.
25. Umpierrez G.E., Smiley D., Jacobs S., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care 2011, 34:256-261.
26. Moghissi E.S., Korytkowski M.T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009, 15:353-369.